<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">For pharmacokinetic (PK) analyses, plasma IMGN529 concentrations were evaluated using validated enzyme-linked immunosorbent assays with a lower limit of quantitation of 19.9Â ng/mL (PRA Health Sciences, Lenexa, KS, USA). Plasma concentrations along with relative actual times were used to calculate the PK parameters listed for cycle 1 using noncompartmental methods.</p>
